Amgen Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Amgen Inc.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
/ 
Frequently asked questions
To buy Amgen Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Amgen Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Amgen Inc. is AMGN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Amgen Inc. has its primary listing on NASDAQ. You can trade Amgen Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Amgen Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Amgen Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Amgen Inc..